429 related articles for article (PubMed ID: 15861411)
41. Supratentorial Cortical Ependymomas: A Retrospective Series of 13 Cases at a Single Center.
Wang M; Zhang R; Liu X; Li D; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
World Neurosurg; 2018 Apr; 112():e772-e777. PubMed ID: 29408575
[TBL] [Abstract][Full Text] [Related]
42. Clear cell ependymoma: a mimicker of oligodendroglioma--report of three cases.
Jain D; Sharma MC; Arora R; Sarkar C; Suri V
Neuropathology; 2008 Aug; 28(4):366-71. PubMed ID: 18248576
[TBL] [Abstract][Full Text] [Related]
43. [Primary cerebral tumors in children. II: Topography and treatment].
Carrie C; Bouffet E; Brunat-Mentigny M; Philip T; Lacroze M
Bull Cancer; 1989; 76(3):255-72. PubMed ID: 2660940
[TBL] [Abstract][Full Text] [Related]
44. Pathobiology of pituitary adenomas and carcinomas.
Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
[TBL] [Abstract][Full Text] [Related]
45. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
[TBL] [Abstract][Full Text] [Related]
47. Cytologic features of ependymomas in smear preparations.
Ng HK
Acta Cytol; 1994; 38(3):331-4. PubMed ID: 8191821
[TBL] [Abstract][Full Text] [Related]
48. Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression.
Hagel C; Treszl A; Fehlert J; Harder J; von Haxthausen F; Kern M; von Bueren AO; Kordes U
J Neurooncol; 2013 Apr; 112(2):191-7. PubMed ID: 23371454
[TBL] [Abstract][Full Text] [Related]
49. Cerebrospinal fluid cytology in patients with ependymoma: a bi-institutional retrospective study.
Qian X; Goumnerova LC; De Girolami U; Cibas ES
Cancer; 2008 Oct; 114(5):307-14. PubMed ID: 18698591
[TBL] [Abstract][Full Text] [Related]
50. Atypical neuronal-glial tumors of cerebral hemispheres in adults with PNET-like component: clinicopathological features of 5 cases.
Takeuchi H; Kubota T; Sato K; Yao Y; Kitai R; Arishima H
Clin Neuropathol; 2003; 22(2):47-56. PubMed ID: 12670050
[TBL] [Abstract][Full Text] [Related]
51. [Intracranial, intrarachindial ependymomas. IV. Subtentorial intracranial ependymomas].
Goutelle A
Neurochirurgie; 1977 May; 23 Suppl 1():53-109. PubMed ID: 593492
[No Abstract] [Full Text] [Related]
52. Supratentorial cortical ependymoma: report of three cases.
Roncaroli F; Consales A; Fioravanti A; Cenacchi G
Neurosurgery; 2005 Jul; 57(1):E192; discussion E192. PubMed ID: 15987557
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical investigation of p53 and EGFR expression of oligodendrogliomas.
Broholm H; Bols B; Heegaard S; Braendstrup O
Clin Neuropathol; 1999; 18(4):176-80. PubMed ID: 10442459
[TBL] [Abstract][Full Text] [Related]
54. [Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors].
Figarella-Branger D; Metellus P; Barrié M; Maues de Paula A; Fernandez C; Polivka M; Vital A; Labrousse F; Vignaud JM; Laquerrière A; Rousselet MC; Lacroix C; Saikali S; Chapon F; Gontier MF; Chrétien F; Babin P; Rigau V; Vandenbos F; Peoc'h M; Kujas M; Chinot O; Gouvernet J; Giorgi R; Guyotat J; Jouvet A
Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):76-84. PubMed ID: 17445840
[TBL] [Abstract][Full Text] [Related]
55. Subependymoma revisited: clinicopathological evaluation of 83 cases.
Rushing EJ; Cooper PB; Quezado M; Begnami M; Crespo A; Smirniotopoulos JG; Ecklund J; Olsen C; Santi M
J Neurooncol; 2007 Dec; 85(3):297-305. PubMed ID: 17569000
[TBL] [Abstract][Full Text] [Related]
56. Supratentorial tanycytic ependymoma.
Richards AL; Rosenfeld JV; Gonzales MF; Ashley D; Mc Lean C
J Clin Neurosci; 2004 Nov; 11(8):928-30. PubMed ID: 15519882
[TBL] [Abstract][Full Text] [Related]
57. Ependymoma.
Reni M; Gatta G; Mazza E; Vecht C
Crit Rev Oncol Hematol; 2007 Jul; 63(1):81-9. PubMed ID: 17482475
[TBL] [Abstract][Full Text] [Related]
58. [Clinicopathologic analysis of ependymoma in childhood].
Zhou B; Li J; Luo Z
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):369-71. PubMed ID: 8732095
[TBL] [Abstract][Full Text] [Related]
59. Supratentorial extraventricular WHO grade III (anaplastic) ependymoma 17 years after total removal of WHO grade II ependymoma of the fourth ventricle.
Takeda N; Nishihara M; Harada T; Kidoguchi K; Hashimoto K
Br J Neurosurg; 2017 Apr; 31(2):270-272. PubMed ID: 27215793
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases.
de Andrade FG; Marie SK; Uno M; Matushita H; Taricco MA; Teixeira MJ; Rosemberg S; Oba-Shinjo SM
Neuropathology; 2015 Aug; 35(4):312-23. PubMed ID: 25946121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
